13F

Stock

BioXcel Therapeutics, Inc.

BTAI · held by 3 managers

Reported value

$21

Holders

3

+1 new · −0 exited

Holders’ est. mark

−$3

Price effect on 2 books still in the name

Largest holder

$14

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC8$14−$2Cut−$3.86K
DANSKE BANK A/S3$5−$1Cut−$1
ELEVATION POINT WEALTH PARTNERS, LLC1$2New

Positions as of Q2 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.